Treatment of allergic rhinitis: does it make a difference in sleep and quality of life?
Allergologia et Immunopathologia · 01.05.2026 · 54 (3) · 81-86
DOI: 10.15586/aei.v54i3.1501 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Allergologia et Immunopathologia, online erschienen am 01.05.2026. Verfasst von Mehmet Özkaya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Allergy, Department of Pediatrics, Faculty of Medicine, Erciyes University, Kayseri, Türkiye; dr.mehmetozk@gmail.com. Hauptthemen laut MEDLINE: Quality of Life, Rhinitis, Allergic, Sleep Quality, Sleep. Gefördert von: This study was funded by the author, and no additional grants were received..
Abstract (Originalsprache)
Objective
Allergic rhinitis (AR) and allergic conjunctivitis (AC) are common atopic conditions of childhood that significantly impair sleep quality and health-related quality of life (HRQoL). Although effective treatment strategies exist, their broader impact on sleep and daily functioning has remained underexplored. This study aimed to evaluate the effect of AR and/or AC treatment on sleep quality and HRQoL in children using validated, parent-reported instruments.
Methods
In this prospective observational cohort study, 98 children aged 6–13 years with AR and/or AC were treated according to standard guidelines. Sleep quality and HRQoL were assessed pre- and post-treatment using the Children’s Sleep Habits Questionnaire (CSHQ) and the Pediatric Rhinoconjunctivitis Quality of Life Questionnaire (PRQLQ), respectively. Changes in scores were analyzed using the Wilcoxon Signed-Rank test.
Results
Post-treatment evaluations demonstrated a significant reduction in total CSHQ scores (median: 56–43, P < 0.001), indicating improved sleep quality. Similarly, total PRQLQ scores decreased significantly (median: 3.47–2.28, P < 0.001), reflecting enhanced QoL. Improvements were observed in most subdomains, including nose and eye symptoms, activity limitations, and other symptoms.
Conclusions
A 4-week standard treatment regimen for AR and/or AC led to significant improvements in sleep quality and HRQoL in children. These findings highlight the importance of early and appropriate management of allergic conditions to enhance both physical and functional well-being in pediatric patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Allergy, Department of Pediatrics, Faculty of Medicine, Erciyes University, Kayseri, Türkiye; dr.mehmetozk@gmail.com.
- Division of Pediatric Allergy, Department of Pediatrics, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
- Department of Child and Adolescent Psychiatry, Faculty of Medicine, Erciyes University, Kayseri, Türkiye.
Förderung
- This study was funded by the author, and no additional grants were received.
Zitieren
APA
Özkaya, M., Bayazıt, Z., Erdoğan, B. Ö., Özdamar, E., Gül, M. K., & Tahan, F. (2026). Treatment of allergic rhinitis: does it make a difference in sleep and quality of life?. Allergologia et Immunopathologia, 54(3), 81-86. https://doi.org/10.15586/aei.v54i3.1501
Vancouver
Özkaya M, Bayazıt Z, Erdoğan BÖ, Özdamar E, Gül MK, Tahan F. Treatment of allergic rhinitis: does it make a difference in sleep and quality of life?. Allergologia et Immunopathologia. 2026;54(3):81-86. doi:10.15586/aei.v54i3.1501
BibTeX
@article{zkaya2026,
author = {Özkaya, Mehmet and Bayazıt, Zehra and Erdoğan, Burcu Özge and Özdamar, Emre and Gül, Melike Kevser and Tahan, Fulya},
title = {Treatment of allergic rhinitis: does it make a difference in sleep and quality of life?},
journal = {Allergologia et Immunopathologia},
year = {2026},
volume = {54},
number = {3},
pages = {81--86},
doi = {10.15586/aei.v54i3.1501}
}
EUVIMED